pubmed-article:16341336 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16341336 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:16341336 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:16341336 | lifeskim:mentions | umls-concept:C0033137 | lld:lifeskim |
pubmed-article:16341336 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
pubmed-article:16341336 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
pubmed-article:16341336 | lifeskim:mentions | umls-concept:C0021641 | lld:lifeskim |
pubmed-article:16341336 | lifeskim:mentions | umls-concept:C0453952 | lld:lifeskim |
pubmed-article:16341336 | lifeskim:mentions | umls-concept:C0205099 | lld:lifeskim |
pubmed-article:16341336 | lifeskim:mentions | umls-concept:C1998548 | lld:lifeskim |
pubmed-article:16341336 | lifeskim:mentions | umls-concept:C0173022 | lld:lifeskim |
pubmed-article:16341336 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:16341336 | pubmed:dateCreated | 2005-12-12 | lld:pubmed |
pubmed-article:16341336 | pubmed:abstractText | The majority of patients with type 2 diabetes mellitus in Cape Town who attend primary care community health centres (CHCs) have unsatisfactory glycaemic control. Insulin is rarely prescribed despite its being indicated for type 2 diabetic patients with inadequate metabolic control on maximum oral glucose-lowering agent (OGLA) therapy. | lld:pubmed |
pubmed-article:16341336 | pubmed:language | eng | lld:pubmed |
pubmed-article:16341336 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16341336 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16341336 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16341336 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16341336 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16341336 | pubmed:month | Oct | lld:pubmed |
pubmed-article:16341336 | pubmed:issn | 0256-9574 | lld:pubmed |
pubmed-article:16341336 | pubmed:author | pubmed-author:LevittN SNS | lld:pubmed |
pubmed-article:16341336 | pubmed:author | pubmed-author:HaqueMM | lld:pubmed |
pubmed-article:16341336 | pubmed:author | pubmed-author:DennisonC RCR | lld:pubmed |
pubmed-article:16341336 | pubmed:author | pubmed-author:EmersonS HSH | lld:pubmed |
pubmed-article:16341336 | pubmed:author | pubmed-author:NavsaMM | lld:pubmed |
pubmed-article:16341336 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16341336 | pubmed:volume | 95 | lld:pubmed |
pubmed-article:16341336 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16341336 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16341336 | pubmed:pagination | 798-802 | lld:pubmed |
pubmed-article:16341336 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:16341336 | pubmed:meshHeading | pubmed-meshheading:16341336... | lld:pubmed |
pubmed-article:16341336 | pubmed:meshHeading | pubmed-meshheading:16341336... | lld:pubmed |
pubmed-article:16341336 | pubmed:meshHeading | pubmed-meshheading:16341336... | lld:pubmed |
pubmed-article:16341336 | pubmed:meshHeading | pubmed-meshheading:16341336... | lld:pubmed |
pubmed-article:16341336 | pubmed:meshHeading | pubmed-meshheading:16341336... | lld:pubmed |
pubmed-article:16341336 | pubmed:meshHeading | pubmed-meshheading:16341336... | lld:pubmed |
pubmed-article:16341336 | pubmed:meshHeading | pubmed-meshheading:16341336... | lld:pubmed |
pubmed-article:16341336 | pubmed:meshHeading | pubmed-meshheading:16341336... | lld:pubmed |
pubmed-article:16341336 | pubmed:meshHeading | pubmed-meshheading:16341336... | lld:pubmed |
pubmed-article:16341336 | pubmed:meshHeading | pubmed-meshheading:16341336... | lld:pubmed |
pubmed-article:16341336 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16341336 | pubmed:articleTitle | Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town. | lld:pubmed |
pubmed-article:16341336 | pubmed:affiliation | Primary Health Care, Department of Public Health, University of Cape Town Cape Town, South Africa. | lld:pubmed |
pubmed-article:16341336 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16341336 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16341336 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16341336 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16341336 | lld:pubmed |